Nathalie Théou–Anton

Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer

Sandra Assoun, Nathalie Théou–Anton, Marina Nguenang et al. · Lung Cancer · 2019 · 173 citations

Life Sciences, Immunology, Oncology +17

MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors

Jérôme Cros, Olivia Hentic, Vinciane Rebours et al. · Endocrine Related Cancer · 2016 · 110 citations · Full text

Medicine, Oncology, Pharmacology +17

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study

Camille Mehlman, Jacques Cadranel, G. Rousseau-Bussac et al. · Lung Cancer · 2019 · 87 citations · Full text

Medicine, Oncology, Pharmacology +16

<i>KIT</i> Mutations Induce Intracellular Retention and Activation of an Immature Form of the KIT Protein in Gastrointestinal Stromal Tumors

Séverine Tabone‐Eglinger, Frédéric Subra, Hiba El Sayadi et al. · Clinical Cancer Research · 2008 · 79 citations

Medicine, Cell Biology, Oncology +16

Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses

Alice Guyard, Claire Danel, Nathalie Théou–Anton et al. · Respiratory Research · 2017 · 58 citations · Full text

Medicine, Oncology, Pathology +17